Other Information.
−Removed: On May 11, 2023, we issued a press release announcing our financial results for the quarter ended March 31, 2023.
+Added: On August 3, 2023, we issued a press release announcing our financial results for the quarter ended June 30, 2023.
A copy of the news release is attached to this Quarterly Report as Exhibit 99.1.
3 unchanged sentences
Certification of Chief Executive Officer and Chief Financial Officer of the Company in accordance with Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
−Removed: Press Release for Quarter Ended March 31, 2022 (filed herewith).
+Added: Press Release for Quarter Ended June 30, 2023 (filed herewith).
Inline XBRL Instance Document
8 unchanged sentences
Fennec Pharmaceuticals Inc.
+Added: August 7, 2023
/s/ Rostislav Raykov
2 unchanged sentences
(principal executive officer)
+Added: August 7, 2023
/s/ Robert Andrade
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.